|
(11) | EP 4 580 679 A1 |
(12) |
|
|
|
|
|||||||||||||||||||||||||||
(54) | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS AND NMDA RECEPTOR ANTAGONISTS |